2015
Overview
Oncology is the field of medicine that deals with the study and treatment of cancer. It is a complex and rapidly evolving field, with new research findings emerging almost daily. Hematology is closely related to oncology, as it deals with the study of blood-related disorders and diseases, including those that commonly occur in cancer patients. One of the key areas of research in hematology and oncology is the development of new oncology agents - drugs and therapies that can help prevent, diagnose, or treat cancer. These may include chemotherapy drugs, targeted therapies, immunotherapy, and more. The development of new oncology agents is a highly specialized process, requiring a deep understanding of the biology of cancer at the molecular level, as well as expertise in clinical trial design, regulatory requirements, and more. Researchers in the field of hematology and oncology work tirelessly to find new and more effective treatments for cancer patients, aiming to improve survival rates and quality of life. One key challenge in oncology research is the heterogeneity of cancer - that is, the fact that different types of cancer may have very different genetic profiles, behaviors, and response to treatment. There is no "one-size-fits-all" approach to cancer treatment, and researchers must constantly explore new avenues in order to find the best possible treatments for each patient. Overall, oncology research is a vital and constantly evolving field, with the potential to save millions of lives in the years to come. By developing better oncology agents, researchers are helping to fight one of the most deadly and devastating diseases of our time.
Research published in this journal
1 peer-reviewed article, ranked by relevance. Each links to its DOI.